PTK2 and cancer: NET-associated NE and MMP9 cleave laminin and degrade thrombospondin-1 leading to the activation of integrin α3β1 and FAK/ERK/MLCK/YAP signaling, resulting in reactivation of dormant cancer cells during tumor metastasis.